Prostatic cancer treatments ‘Jevtana’ and ‘Zytiga’ newly registered in list of health insurance benefits this May

104 products, such as Jevtana and Zytiga, prostate cancer therapies, will be newly registered in the list of health insurance benefits this May.

The Ministry of Health and Welfare(MOHW) revised and placed the ‘Drug Insurance Benefit List and Upper Limit Table’ on the 23^rd.

When it comes to the anticancer drug section in the list, ‘Jevtana Inj,’ a Sanofi-Aventis Korea’s prostate cancer therapy...